semaglutide weight loss graph Two-year effects of in adults with overweight or obesity: the STEP 5 trial My weight loss chart! :

Riot Platforms: A $311M AMD Deal Changes the HPC Game America's Weight-Loss Fixation Is Driving Massive Growth Industry consultancy firm Grand View Research forecasts the GLP-1 drug market to grow by a compound annual growth rate of 18.54% between 2024 and 2030, resulting in a global market value increase from $13.84 to $48.84 billion

Morgante CV, Rodrigues RA, Marbach PA, Borgonovi CM, Moura DS, Silva-Filho MC

Am Rev Respir Dis, 142: 863-871

Retatrutide is an investigational drug that is not approved by the FDA or any regulatory body for the treatment of obesity, diabetes, or body recomposition outside of clinical trials

Unlike stimulants, which can be addictive, these drugs may fight addictions and not just those related to food